As a result of using Defendants Ozempic and Mounjaro, Plaintiff was caused to suffer from severe gastrointestinal events, which resulted in, for example, severe vomiting, stomach pain, gastrointestinal burning, being hospitalized for stomach issues on several occasions including visits to the emergency room, teeth falling out due to excessive vomiting, requiring additional medications to alleviate her excessive vomiting, and throwing up whole food hours after eating. The lawsuit explains: Defendants acknowledge that gastrointestinal events are well known side effects of the GLP-1 class
The catalog numbers were as follows: GSK3 (MBS766198), Bace1 (MBS2886958), BDNF (MBS824814), IGF-1 (MBS176012), ATPase (MBS264916), ADA (MBS267634), AChE (MBS725468), and BChE (MBS2022207)
10.1002/jts.2490080106 41
Generic pre-op forms often only ask about regular medications, which patients skip because: Many do not count weight loss shots as medicine Some feel embarrassed about using weight loss drugs They simply do not know these matter to Anaesthetists AusDoc reported this trend last year in an article Anaesthetists forced to cancel procedures because of patients keeping quiet about GLP-1 receptor agonists
Proper titration, starting low and escalating slowly, dramatically reduces early GI issues
Sermorelin and CJC-1295 both work this way
